Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | LOX | P28300 | 1/20 | 0.30 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.30 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29285235 | 0.89 | MEN1 (0.33) | TSHR | |
| SCHEMBL21902646 | 0.85 | TSHR (0.44) | ALDH1A1CYP3A4TSHR | |
| SCHEMBL11388050 | 0.84 | TSHR (0.36) | ALDH1A1TDP1TSHR | |
| SCHEMBL13625441 | 0.83 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL26212788 | 0.83 | TSHR (0.30) | TSHR | |
| SCHEMBL11363024 | 0.82 | TSHR (0.35) | ALDH1A1TDP1TSHR | |
| SCHEMBL4608718 | 0.82 | TSHR (0.35) | ALDH1A1TDP1TSHR | |
| SCHEMBL26001122 | 0.80 | — | — | |
| SCHEMBL22036458 | 0.79 | — | — | |
| SCHEMBL21886211 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023082869-A1 | SECONDARY BATTERY, METHOD FOR PREPARING SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK, AND POWER CONSUMPTION APPARATUS | 宁德时代新能源科技股份有限公司 | 2023-05-19 | — | — | WO | claimed |
| CN-116111178-A | Secondary battery, method for manufacturing secondary battery, battery module, battery pack, and electricity using device | 宁德时代新能源科技股份有限公司 | 2023-05-12 | — | — | CN | claimed |
| EP-3775957-A1 | MATERIALS WITH HIGH DIELECTRIC CONSTANT FOR MAGNETIC RESONANCE IMAGING INSTRUMENTS | Centre National de la Recherche Scientifique - CNRS (FR) | 2021-02-17 | — | — | EP | claimed |
| US-9090539-B2 | Compounds and methods for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds | AMPAC FINE CHEMICALS LLC (US) | 2015-07-28 | — | — | US | claimed |
| CN-111971803-B | Polymerizable self-assembling monomers for atomic layer deposition | 国际商业机器公司 | 2024-06-21 | — | — | CN | disclosed |
| EP-3334745-B1 | CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS | MERCK SHARP & DOHME LLC (US) | 2024-05-15 | — | — | EP | disclosed |
| US-11692079-B2 | 2-dimensional MXene particle surface-modified with functional group containing saturated or unsaturated hydrocarbon, preparation method thereof and use thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-07-04 | — | — | US | disclosed |
| WO-2023082869-A1 | SECONDARY BATTERY, METHOD FOR PREPARING SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK, AND POWER CONSUMPTION APPARATUS | 宁德时代新能源科技股份有限公司 | 2023-05-19 | — | — | WO | disclosed |
| CN-116111178-A | Secondary battery, method for manufacturing secondary battery, battery module, battery pack, and electricity using device | 宁德时代新能源科技股份有限公司 | 2023-05-12 | — | — | CN | disclosed |
| CN-116111178-A | Secondary battery, method for manufacturing secondary battery, battery module, battery pack, and electricity using device | 宁德时代新能源科技股份有限公司 | 2023-05-12 | — | — | CN | disclosed |
| US-11505571-B2 | Compounds and compositions for treating conditions associated with sting activity | INNATE TUMOR IMMUNITY, INC. (US) | 2022-11-22 | — | — | US | disclosed |
| CN-114380727-A | Preparation method of 2- [1- (ethylsulfonyl) -3-azetidine ] acetonitrile | 南京焕然生物科技有限公司 | 2022-04-22 | — | — | CN | disclosed |
| US-20130040209-A1 | NONAQUEOUS ELECTROLYTE SOLUTION CONTAINING CYCLIC SULFONE COMPOUND, AND LITHIUM SECONDARY BATTERY | MITSUI CHEMICALS, INC. (JP) | 2013-02-14 | — | — | US | disclosed |
| CN-102870268-A | Nonaqueous electrolyte solution containing cyclic sulfone compound, and lithium secondary battery | MITSUI CHEMICALS INC | 2013-01-09 | — | — | CN | disclosed |
| CN-101654279-B | Amphiphilic Dispersible Nano Titanium Dioxide Material | IND TECH RES INST | 2012-03-21 | — | — | CN | disclosed |
| CN-101654279-A | Amphiphilic Dispersible Nano Titanium Dioxide Material | IND TECH RES INST | 2010-02-24 | — | — | CN | disclosed |
| EP-0745586-B1 | Aryl(alkyl) propylamides, process for their preparation and pharmaceutical compositions containing them | ADIR (FR) | 2000-03-08 | — | — | EP | disclosed |
| EP-0745586-A1 | Aryl(alkyl) propylamides, process for their preparation and pharmaceutical compositions containing them | ADIR ET COMPAGNIE (FR) | 1996-12-04 | — | — | EP | disclosed |
| US-5268464-A | Process for the preparation of nucleosides | CIBA-GEIGY CORPORATION (US) | 1993-12-07 | — | — | US | disclosed |
| US-4431576-A | COSMETICS; TOILETRIES; DETERGENTS; INSECTICIDES; WAXES | ROUSSEL UCLAF (FR) | 1984-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11505571-B2 | Compounds and compositions for treating conditions associated with sting activity | STING1, CGAS, IRF3 | ALDH1A1 4624/4885TDP1 83/4885LOX 1256/4885 |
| US-20130040209-A1 | NONAQUEOUS ELECTROLYTE SOLUTION CONTAINING CYCLIC SULFONE COMPOUND, AND LITHIUM SECONDARY BATTERY | TST, SULT1E1, STS | ALDH1A1 932/4885TDP1 2542/4885LOX 3151/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.